Voloridge Investment Management
PMVP icon

Voloridge Investment Management’s PMV Pharmaceuticals PMVP Stock Holding History

Voloridge Investment Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-252,308
Closed -$2.2M – 1561
2022
Q4 		$2.2M Buy
252,308
+18,266
+8% +$195K 0.01% 937
2022
Q3 		$2.79M Buy
234,042
+157,440
+206% +$2.27M 0.02% 879
2022
Q2 		$1.09M Buy
+76,602
New +$1.11M 0.01% 1165
2022
Q1 		– Sell
-23,971
Closed -$554K – 1634
2021
Q4 		$554K Sell
23,971
-30,446
-56% -$736K ﹤0.01% 1395
2021
Q3 		$1.62M Buy
54,417
+43,739
+410% +$1.4M 0.01% 1126
2021
Q2 		$365K Buy
+10,678
New +$357K ﹤0.01% 1495

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Voloridge Investment Management's PMVP Position: Q1 2023 in Review

Voloridge Investment Management sold out of PMV Pharmaceuticals (PMVP) in Q1 2023, closing a stake of 252,308 shares — an estimated $2.2M sold.

Voloridge Investment Management first reported a position in PMVP in Q2 2021 and held it in 6 quarters. The position peaked at $2.79M in Q3 2022. 111 funds tracked by Wall St. Rank hold PMVP as of Q1 2023.

  • Voloridge Investment Management reported no remaining PMV Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 252,308 PMV Pharmaceuticals shares in Q1 2023, an estimated $2.2M.
  • Voloridge Investment Management first reported a position in PMV Pharmaceuticals in Q2 2021 and held it in 6 quarters.
  • Voloridge Investment Management's PMV Pharmaceuticals position peaked at $2.79M in Q3 2022.
  • 111 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2023.

Based on Voloridge Investment Management's 13F filing for Q1 2023, filed 15 May 2023.